panic disorder

Search with Google Search with Bing
Information
Disease name
panic disorder
Disease ID
DOID:594
Description
"An anxiety disorder that is characterized by unexpected and repeated episodes of intense fear accompanied by physical symptoms that may include chest pain, heart palpitations, shortness of breath, dizziness, or abdominal distress." [url:http\://www.nimh.nih.gov/health/topics/panic-disorder/index.shtml]
Disease area statistics
Chromosome band
Gene symbol Chromosome Start Stop The number of variant
SCN1A 2 165,985,813 166,128,020 4
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT05530642 Active, not recruiting N/A An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel September 22, 2020 December 31, 2024
NCT03899090 Active, not recruiting N/A Floatation-REST (Reduced Environmental Stimulation Therapy) for Anxiety and Depression April 8, 2019 May 31, 2024
NCT05157386 Active, not recruiting Physical Exercise as Adjunctive Therapy for Affective Disorder and Anxiety December 20, 2021 June 2024
NCT04931134 Active, not recruiting N/A Treatment of Anxiety Disorders With Trigeminal Nerve Stimulation February 7, 2022 January 31, 2025
NCT05124639 Active, not recruiting N/A Clinical Trial of a Group Self-management Support Program for Anxiety Disorders October 6, 2022 December 21, 2026
NCT01075672 Active, not recruiting N/A Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals January 2010 January 2025
NCT00031317 Completed Phase 4 Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression February 2002 June 2005
NCT00038896 Completed Phase 3 Study Evaluating Venlafaxine ER in Adults With Panic Disorder April 2001 December 2002
NCT00044772 Completed Phase 3 Study Evaluating Venlafaxine ER in Patients With Panic Disorder November 2001 April 2003
NCT00051207 Completed Phase 1/Phase 2 Therapy for Depression With Co-occurring Panic or Anxiety Symptoms November 2002 August 2005
NCT00063375 Completed Phase 1 Interactive Computer Treatment for Panic Disorder January 2002
NCT00083265 Completed Genetic Causes of Panic Disorder May 13, 2004 February 14, 2018
NCT00088738 Completed Phase 1 Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQ July 27, 2004 September 10, 2008
NCT00101777 Completed Ventilatory Physiology in Children at Risk for Anxiety December 2001 November 2005
NCT00102427 Completed Phase 2/Phase 3 Improving Quality of Primary Care for Patients With Anxiety and/or Panic Disorders July 2000 May 2003
NCT00103987 Completed Neurobiological Mechanisms in Panic Disorder February 14, 2005 November 12, 2010
NCT00118417 Completed Phase 2/Phase 3 Therapies for Treatment-Resistant Panic Disorder Symptoms March 1999 October 2007
NCT00128388 Completed Phase 2/Phase 3 Psychodynamic Therapy for Treating Panic Disorder February 2000 July 2005
NCT00131339 Completed N/A Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder November 2004 March 2007
NCT00141115 Completed Phase 2 Levetiracetam for the Treatment of Alcohol Dependence and Anxiety March 2004 January 2008
NCT00158327 Completed Phase 3 Telephone-Based Care Management Program for Individuals With Anxiety Disorders March 2004 February 2011
NCT00167479 Completed Phase 4 A Study of Risperidone Monotherapy in Bipolar Anxiety September 2003 September 2006
NCT00183521 Completed N/A Breathing Regulation Training for Individuals With Panic Disorder March 2005 November 2008
NCT00198094 Completed Phase 4 A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder Patients December 2003 September 2007
NCT00266409 Completed Phase 4 Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder October 2005 June 2006
NCT00279617 Completed Phase 3 Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks January 2006 March 2009
NCT00344474 Completed Phase 2/Phase 3 Personality-targeted Interventions for Adolescent Alcohol Misuse November 2003 July 2008
NCT00347269 Completed Phase 4 Primary Care Intervention Strategy for Anxiety Disorders June 2006 October 2009
NCT00352469 Completed Phase 4 Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety February 2006 November 2008
NCT00353470 Completed Phase 3 Comparison of Psychotherapy Programs to Treat Panic Disorder September 2006 September 2012
NCT00438386 Completed Phase 4 Aripiprazole for the Treatment of Refractory Anxiety April 2005 June 2007
NCT00438971 Completed Phase 4 The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder August 2006 January 2009
NCT00456768 Completed Efficacy of Treatment for Panic Disorder May 2003 April 2011
NCT00457106 Completed N/A A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks June 2002 June 2003
NCT00000368 Completed Phase 3 Treatment of Panic Disorder: Long Term Strategies February 1999 July 2004
NCT00004366 Completed N/A Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular Dysfunction August 1995 May 2000
NCT00004367 Completed N/A Vestibular Dysfunction In Adult Patients With Panic Disorder With or Without Agoraphobia May 2000
NCT00004373 Completed Phase 2 Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety March 1997 March 2001
NCT00004834 Completed N/A Randomized Study of Cognitive-Behavioral Therapy vs Imipramine and Their Combination for Panic Disorder May 1998 June 2005
NCT00025974 Completed Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress Disorder October 31, 2001 July 21, 2008
NCT00803400 Completed Phase 4 Efficacy of Aerobic Exercise Added to Alprazolam in Panic Disorder Treatment October 1, 2008 September 30, 2009
NCT00845260 Completed Phase 3 Internet-Versus Group-Administered Cognitive Behavior Therapy for Panic Disorder December 2004 December 2007
NCT00938093 Completed N/A Treatment of Late-life Anxiety in Primary Care Settings March 2006 February 2009
NCT00947570 Completed N/A Neural Functioning Underlying Anxiety and Its Treatment (The INSULA Study) October 2007 August 2012
NCT01025908 Completed N/A Cognitive Behavior Psychotherapy in Panic Disorder May 2006 April 2007
NCT01076777 Completed Phase 2 Physical Exercise Versus Cognitive-behavioral Therapy (CBT) for Panic Disorders: A Randomised Controlled Trial May 2007 December 2009
NCT01172652 Completed Phase 4 Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD) April 2010 October 2011
NCT01201967 Completed Phase 4 A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients September 2010 June 2013
NCT01371474 Completed Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day) April 2006 June 2008
NCT01376128 Completed Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder) March 2008 May 2009
NCT01385709 Completed The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels August 2008 August 2013
NCT01482806 Completed Phase 2/Phase 3 Online Treatments for Mood and Anxiety Disorders in Primary Care February 2012 May 30, 2017
NCT01551225 Completed Phase 4 Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder January 2012 September 2016
NCT01583296 Completed N/A LUCHAR - Latinos Using Counseling for Help With Asthma and Anxiety Reduction July 2010 December 2013
NCT01632553 Completed Cortisol Evaluation in Abuse Survivors August 2012 October 2014
NCT01788800 Completed N/A Physical Activity and Cognitive Behavioural Therapy in Panic Disorder January 2009 May 2013
NCT01849432 Completed Study of Brain Circuitry in Anxiety Disorders December 2006 July 2011
NCT01928810 Completed N/A Physical Activity and Cognitive Behavioural Therapy in Panic Disorder and Agoraphobia March 2011 February 2014
NCT01947647 Completed N/A Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders November 17, 2014 December 31, 2018
NCT01955954 Completed N/A Using the Canary Breathing System for Panic Disorder Patients September 2013 May 2016
NCT01963806 Completed N/A ACT-smart: Smartphone-supplemented iCBT for Social Phobia and/or Panic Disorder September 2013 November 2015
NCT02082561 Completed N/A False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment for Anxiety Disorders July 2010 September 2012
NCT02150265 Completed N/A Effectiveness of Six Sessions CBT for Adolescents With Emotional Problems in Community Clinics January 1, 2013 March 1, 2018
NCT02266693 Completed N/A Transdiagnostic iCBT for Depression and Anxiety August 2014 August 2018
NCT02395510 Completed Phase 4 A 10-Week, Open-Label, Flexible Dose Adaptive Study Evaluating the Efficacy of Vortioxetine in Subjects With Panic Disorder May 2015 June 2016
NCT02402322 Completed N/A Internet-based Self-help Treatment for Panic Disorder: Two Ways of Complementary Psychological Support August 2013 November 2014
NCT02593682 Completed Phase 4 The Role of Orexin in Human Panic Disorder May 2016 March 13, 2020
NCT02605668 Completed N/A Providing Tools for Effective Care and Treatment of Anxiety Disorders December 12, 2015 July 24, 2019
NCT02615119 Completed N/A Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa October 1, 2015 June 2023
NCT02678624 Completed N/A Project Collabri for Treatment of Anxiety November 2014 July 2020
NCT02756507 Completed N/A Transdiagnostic REBT Prevention Program for Adolescents June 2016 June 2018
NCT02810171 Completed N/A Dimensional Brain Behavior Predictors of CBT Outcomes in Pediatric Anxiety December 2016 November 12, 2021
NCT02811458 Completed N/A Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders September 12, 2016 July 10, 2019
NCT02826096 Completed N/A A Brief Version of Biofeedback Therapy for Panic Disorder December 21, 2015 April 18, 2021
NCT02852577 Completed Phase 4 Long Term Treatment of Panic Disorder With Clonazepam or Paroxetine January 2000 August 2012
NCT02872051 Completed N/A Integrated Mental Health Care and Vocational Rehabilitation to Individuals on Sick Leave Due to Anxiety and Depression April 2016 June 2020
NCT02954731 Completed N/A Trans-diagnostic Group CBT vs. Standard Group CBT for Depression, Social Anxiety and Agoraphobia/Panic Disorder December 2016 December 11, 2019
NCT02998502 Completed N/A The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens September 2016 February 1, 2021
NCT03051074 Completed N/A Examining the Effects of Reduced Environmental Stimulation on Anxiety December 1, 2016 December 31, 2019
NCT03113175 Completed N/A Collabri Flex - Effect of Collaborative Care for People With Anxiety Disorders in General Practice January 15, 2018 March 29, 2021
NCT03118752 Completed N/A Pragmatic Collaborative Care for Cardiac Inpatients With Depression or Anxiety October 16, 2017 March 8, 2024
NCT03143634 Completed Phase 1/Phase 2 The Modular Protocol for Mental Health (MPMH) July 18, 2017 July 31, 2020
NCT03156556 Completed N/A Improving Access to the Treatment of Anxiety and Depression Among Young Adults May 15, 2017 January 31, 2018
NCT03206437 Completed N/A Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli June 20, 2017 November 25, 2022
NCT03233542 Completed N/A The Association Between Physical Sensations and Thinking Styles September 18, 2017 August 31, 2023
NCT03251235 Completed N/A Neural Effects of Cognitive-behaviour Therapy in Panic Disorder January 1, 2011 February 1, 2016
NCT03300232 Completed N/A Adapting an Effective CBT for Comorbidity to a Computer-Delivered Format April 16, 2018 July 26, 2021
NCT03504475 Completed Phase 1 Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers March 29, 2018 June 16, 2018
NCT03522844 Completed Phase 4 Treatments for Anxiety: Meditation and Escitalopram June 18, 2018 January 5, 2022
NCT03785223 Completed Phase 4 A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity April 20, 2019 October 31, 2022
NCT03819426 Completed N/A Walking or High Intensity Exercise for Anxiety December 11, 2018 July 29, 2020
NCT03925987 Completed N/A Predicting Treatment Response to Exposure Therapy Using Carbon Dioxide June 7, 2018 July 31, 2020
NCT03958903 Completed N/A Investigations of Amygdala Function Using Neurophysiological Recording and Stimulation April 24, 2019 March 13, 2020
NCT04160806 Completed N/A The Effect Of Transcranial Direct Current Stimulation In Panic Disorder November 1, 2019 November 1, 2021
NCT04179526 Completed N/A Transdiagnostic Internet-delivered REBT Intervention for Adolescents' Internalizing Problems January 25, 2020 December 30, 2022
NCT04366011 Completed N/A Efficacy and Mechanisms of Psychosocial Treatments for Panic Disorder November 2011 October 2015
NCT04592536 Completed Phase 1 A Trial of the Effect of CVL-865 on Panic Symptoms Induced by Carbon Dioxide Inhalation in Healthy Subjects October 6, 2020 December 13, 2021
NCT04659577 Completed N/A Attitudes of Professionals and the General Public in Israel Regarding ICBT November 1, 2016 January 31, 2022
NCT04922502 Completed Phase 2/Phase 3 Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder July 1, 2021 December 22, 2023
NCT04985019 Completed N/A A Validation Study of Mobile Virtual Reality-Based Self-Care and Exposure Therapy Contents for the Treatment of Panic Disorder November 14, 2018 January 4, 2021
NCT05071430 Completed Phase 2 Safety and Efficacy of HB-1 for Panic Disorder February 3, 2022 December 12, 2022
NCT05261594 Completed N/A Effects of Caffeine on Anxiety, Emotional Processing, Approach-avoidance Behavior, and Interoception in Panic Disorder March 16, 2022 March 19, 2023
NCT05462184 Completed N/A Predictors and Moderators of Cognitive-Behavioral Therapy and Acceptance and Commitment Therapy for Panic Disorder March 2014 July 31, 2016
NCT05832905 Completed Mobile-assisted Case Management for Panic Disorder June 15, 2020 September 30, 2023
NCT06071819 Completed Clinical Markers of Panic and Generalized Anxiety Disorder August 1, 2022 October 31, 2022
NCT06370559 Completed Relationship Between Repetitive Negative Thinking and CBT Outcomes January 1, 2022 February 1, 2024
NCT00521352 Completed Phase 2 Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder With Comorbid Major Depression October 2007 June 2011
NCT00525226 Completed Evaluating the Effects of Stress in Pregnancy September 2007 July 2012
NCT00535964 Completed Evaluating the Relationship Between Tobacco Use, Anxiety Sensitivity, and Panic in Adolescents June 2007 April 2009
NCT00540098 Completed Phase 4 Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder September 2001 June 2005
NCT00576719 Completed Phase 2 Effectiveness of Intensive Cognitive Behavioral Therapy in Treating Adolescent Panic Disorder and Agoraphobia March 2005 March 2011
NCT00579280 Completed Phase 4 Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD July 2007 December 2010
NCT00605813 Completed Special Investigation Of Long Term Use Of Sertraline. September 2007 September 2011
NCT00605865 Completed Drug Use Investigation of Jzoloft. April 2007 September 2011
NCT00605917 Completed Special Investigation Of J Zoloft For Panic Disorder Patients April 2007 September 2011
NCT00619138 Completed Phase 3 Treatment of Social Phobia and Panic Disorder in Adults March 2008 December 2015
NCT00619892 Completed Phase 4 A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder Patients February 2008 December 2011
NCT00628979 Completed N/A Addressing Help-Seeking Barriers in Developing an Intensive Treatment for Veterans With Panic Disorder March 2008 July 2009
NCT00677352 Completed Phase 4 A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder May 2008 February 2010
NCT00688818 Completed N/A Quetiapine in Co-Morbid Depressive and Anxiety Disorders June 2008 June 2013
NCT00705380 Completed Phase 2 Effectiveness of Cognitive Behavioral Therapy With Panic Control Treatment for Adolescents With Panic Disorder July 1998 October 2004
NCT00711737 Completed Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months September 2008 October 2010
NCT00734370 Completed N/A Virtual Reality Exposure Therapy in Agoraphobic Participants October 2008 January 2012
NCT00767754 Completed Phase 4 Changes of Cerebral Glucose Metabolism After 12 Weeks of Paroxetine Treatment in Panic Disorder January 2007 December 2008
NCT00767871 Completed Phase 4 Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder March 2007 December 2008
NCT00772746 Completed Cognitive Behavioral Therapy in Panic Disorder March 2006 March 2007
NCT00776685 Completed Phase 2/Phase 3 Adventure: Teacher Delivered Personality-targeted Interventions for Substance Misuse May 2007 May 2010
NCT00790868 Completed Phase 2 Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder April 2008 August 2014
NCT04634461 Enrolling by invitation The Relationship Between Panic Attack Symptoms and Atrial Fibrillation Episodes. March 15, 2021 August 30, 2024
NCT06145490 Not yet recruiting N/A Neurobehavioral Correlates of Caffeine on Anxiety, Avoidance and Interoception in Healthy Individuals and Panic Disorder. August 2024 March 2025
NCT05737511 Not yet recruiting Phase 4 Efficacy of Hydroxyzine for Patients With Panic Disorder December 30, 2023 December 30, 2026
NCT05118594 Not yet recruiting N/A Testing a Precision Psychotherapy System for Low-income Patients February 2026 November 2026
NCT06422728 Not yet recruiting N/A The Effectiveness of Transdiagnostic CBT Protocol on Anxiety Disorders June 2024 January 2025
NCT03549819 Recruiting Phase 3 Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study December 15, 2021 February 2024
NCT06132659 Recruiting N/A Neurofeedback Enhanced Cognitive Reappraisal Training April 22, 2024 July 2025
NCT04048824 Recruiting N/A Optimizing Exposure Therapy for Anxiety Disorders August 14, 2015 June 1, 2024
NCT05203731 Recruiting N/A Level of Physical Activity and Fear Learning January 31, 2023 January 14, 2025
NCT05868135 Recruiting Effects and Cost-effectiveness of e-Meistring - a Guided Internet-delivered Psychological Treatment September 9, 2021 December 31, 2027
NCT05249543 Recruiting N/A Transdiagnostic Versus Diagnosis-specific Cognitive-behavioral Therapy March 1, 2022 June 2024
NCT04900064 Recruiting N/A Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial June 14, 2021 December 31, 2026
NCT05467683 Recruiting N/A CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy November 2, 2022 February 28, 2027
NCT05321628 Recruiting N/A Evaluating Clinical Routines for ICBT December 3, 2021 September 2025
NCT02305537 Recruiting N/A Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment October 2014 October 2070
NCT05663489 Recruiting Neurobiological Markers of Treatment Response for Anxiety and OCD March 23, 2018 December 11, 2027
NCT05427708 Recruiting N/A Respiratory Training vs Interoceptive Exposure in the Treatment of Transdiagnostic Pathological Anxiety August 22, 2022 May 2025
NCT05510804 Recruiting N/A Efficacy of an App-based CBT Featuring Virtual Reality for Anxiety Disorders March 3, 2020 March 1, 2023
NCT05671419 Recruiting N/A Mindful Self-Compassion for Anxiety Disorders and Depression January 16, 2022 July 2026
NCT05527509 Recruiting N/A Risk and Resiliency Factors in the RCMP: A Prospective Investigation April 22, 2019 December 2029
NCT05941442 Recruiting Phase 2 A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder July 31, 2023 April 2025
NCT05967468 Recruiting N/A Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder September 14, 2023 March 2025
NCT05117255 Recruiting N/A Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity January 4, 2022 March 1, 2026
NCT03528109 Recruiting N/A Improving Access to Child Anxiety Treatment July 1, 2018 February 1, 2025
NCT00206765 Terminated Phase 2 Risperidone vs. Paroxetine for Panic Attacks January 2003 July 2005
NCT00635076 Terminated Phase 4 A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder July 2004 September 2004
NCT00635531 Terminated Phase 4 A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder April 2004 September 2004
NCT04714164 Terminated N/A Cognitive Behavioral Therapy Group for Older Adults Delivered by Telethealth February 18, 2021 September 15, 2023
NCT01671033 Terminated N/A Treatment of Panic Disorder Via Internet With a Wireless Temperature Biofeedback Ring February 2010 January 2011
NCT00725725 Terminated Phase 2 Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705) July 23, 2008 April 23, 2010
NCT01680107 Terminated Phase 3 D-cycloserine Augmented CBT for Panic Disorder October 2012 April 30, 2018
NCT00634790 Terminated Phase 4 A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks May 2004 October 2004
NCT00322803 Terminated Phase 2 ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Dose and One Week of Treatment May 2006 October 2006
NCT00746239 Terminated N/A Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for Anxiety August 2008 July 2010
NCT00182533 Terminated Phase 4 Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders July 2002 January 2018
NCT00825136 Terminated N/A Treatment of Panic Disorder Via Internet With a Wireless Temperature Biofeedback Ring July 2008 May 2009
NCT00930657 Terminated CO2 Inhalation and Risk for Panic Disorder June 26, 2009 August 12, 2019
NCT01323556 Unknown status Phase 2/Phase 3 Mechanisms of Panic Disorders Treatment March 2010 May 2012
NCT04185896 Unknown status Perinatal Mental Health Care in Switzerland July 10, 2019 February 29, 2020
NCT02476136 Unknown status Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis May 2015 December 2016
NCT04432155 Unknown status Phase 2/Phase 3 Xenon Inhalation for Treatment of Panic Disorder June 2021 December 2021
NCT04433832 Unknown status Physical and Psychological Health Trajectories in the Context of Coronary Heart Disease January 20, 2020 November 30, 2023
NCT02631694 Unknown status Phase 2 Disruption of Memory Reconsolidating as a Treatment for Panic Disorder April 2016 September 2019
NCT02739607 Unknown status N/A Internet-delivered Transdiagnostic Intervention for Anxiety and Depression April 2016 March 2017
NCT04911933 Unknown status N/A Development of Mental Health Outcomes Following the 2020 Petrinja Earthquake January 4, 2021 December 31, 2021
NCT00736346 Unknown status N/A Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain October 2005 June 2010
NCT03015285 Unknown status N/A CBT for Anxiety Sensitivity vs. Disorder-specific CBT: An RCT January 2017 August 2019
NCT03188575 Unknown status N/A Effectiveness & Cost-effectiveness of Internet-delivered Interventions for Depression and Anxiety Disorders in IAPT June 15, 2017 August 30, 2019
NCT03199625 Unknown status Phase 2 Different Neural Circuit Mechanisms Between Cognitive Therapy and Behavior Therapy for Patients With Panic Disorder: a Dynamic Research January 2016 December 2019
NCT00168506 Unknown status N/A Panic Disorder and Cardiac Risk June 2002 December 2008
NCT00492414 Unknown status Phase 4 Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release
NCT03360578 Unknown status Measuring Physiology to Determine if Pre-panic Attack Detection is Possible October 1, 2018 December 31, 2022
NCT00515996 Unknown status Genetic Abnormalities and Biological Changes of Panic Disorder Patients After Pharmacotherapy January 2006 December 2008
NCT01346241 Unknown status N/A Improving Access To Services to Community Based Outpatient Clinics (CBOC's) April 2011 April 2013
NCT03498599 Unknown status N/A Neuroimaging of Pavlovian Fear Conditioning Processes in Patients With Pathological Anxiety August 1, 2017 June 2020
NCT03507114 Unknown status N/A Rumination Focus Cognitive Behavior Therapy March 27, 2018 February 27, 2019
NCT01674673 Unknown status A Long-term Observational Study on the Efficacy of SSRIs or Combined Treatment(SSRIs+ CBT) in Panic Disorder Patients February 2012 October 2014
NCT01677429 Unknown status N/A The Assessment and Treatment of Balance Impairment Using Virtual Reality (VR) in Panic Disorder Patients June 2015 September 2016
NCT03885453 Unknown status Construction of a Questionnaire on Panic Disorder and Agoraphobia March 2019 December 1, 2022
NCT01906268 Unknown status N/A Attention Retraining for Anxiety Disorder Patients Resistent to Antidepressants July 2013
NCT03917550 Unknown status N/A RECOVERY: A Transdiagnostic Intervention for Anxiety and Depression March 18, 2019 March 27, 2020
NCT04029740 Unknown status N/A Exosomal microRNAs as a Biomarker in Panic Disorder and in Response to CBT March 24, 2019 December 24, 2021
NCT00129610 Unknown status N/A Study of Virtual Reality Therapy and Cognitive Behavior Therapy in Panic Disorder With Agoraphobia January 2004
NCT02336802 Unknown status Threat-Avoidance Learning in Anxiety Patients January 2016 December 2018
NCT01008371 Withdrawn Investigation of Neuro-hormonal Mechanisms of Hunger, Fullness and Obesity. October 2009 March 2013
NCT04569760 Withdrawn Phase 3 Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study April 2021 June 2023
Disase is a (Disease Ontology)
DOID:2030
Cross Reference ID (Disease Ontology)
EFO:0004262
Cross Reference ID (Disease Ontology)
ICD10CM:F41.0
Cross Reference ID (Disease Ontology)
MESH:D016584
Cross Reference ID (Disease Ontology)
MIM:167870
Cross Reference ID (Disease Ontology)
MIM:607853
Cross Reference ID (Disease Ontology)
MIM:609985
Cross Reference ID (Disease Ontology)
NCI:C34890
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:191705007
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0030319
Exact Synonym (Disease Ontology)
panic anxiety syndrome